Weighted Gene Co-Expression Network Analysis and Treatment Strategies of Tumor Recurrence-Associated Hub Genes in Lung Adenocarcinoma

Despite the recent progress of lung adenocarcinoma (LUAD) therapy, tumor recurrence remained to be a challenging factor that impedes the effectiveness of treatment. The objective of the present study was to predict the hub genes affecting LUAD recurrence via weighted gene co-expression network analy...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zhengze Shen, Shengwei Liu, Jie Liu, Jingdong Liu, Caoyuan Yao
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/a3f7ee460a62453695bb1b0edecb5f99
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a3f7ee460a62453695bb1b0edecb5f99
record_format dspace
spelling oai:doaj.org-article:a3f7ee460a62453695bb1b0edecb5f992021-11-16T07:40:13ZWeighted Gene Co-Expression Network Analysis and Treatment Strategies of Tumor Recurrence-Associated Hub Genes in Lung Adenocarcinoma1664-802110.3389/fgene.2021.756235https://doaj.org/article/a3f7ee460a62453695bb1b0edecb5f992021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fgene.2021.756235/fullhttps://doaj.org/toc/1664-8021Despite the recent progress of lung adenocarcinoma (LUAD) therapy, tumor recurrence remained to be a challenging factor that impedes the effectiveness of treatment. The objective of the present study was to predict the hub genes affecting LUAD recurrence via weighted gene co-expression network analysis (WGCNA). Microarray samples from LUAD dataset of GSE32863 were analyzed, and the modules with the highest correlation to tumor recurrence were selected. Functional enrichment analysis was conducted, followed by establishment of a protein–protein interaction (PPI) network. Subsequently, hub genes were identified by overall survival analyses and further validated by evaluation of expression in both myeloid populations and tissue samples of LUAD. Gene set enrichment analysis (GSEA) was then carried out, and construction of transcription factors (TF)–hub gene and drug–hub gene interaction network was also achieved. A total of eight hub genes (ACTR3, ARPC5, RAB13, HNRNPK, PA2G4, WDR12, SRSF1, and NOP58) were finally identified to be closely correlated with LUAD recurrence. In addition, TFs that regulate hub genes have been predicted, including MYC, PML, and YY1. Finally, drugs including arsenic trioxide, cisplatin, Jinfukang, and sunitinib were mined for the treatment of the eight hub genes. In conclusion, our study may facilitate the invention of targeted therapeutic drugs and shed light on the understanding of the mechanism for LUAD recurrence.Zhengze ShenShengwei LiuJie LiuJingdong LiuCaoyuan YaoFrontiers Media S.A.articlelung adenocarcinomatumor recurrenceweighted gene co-expression network analysishub genestranscription factorGeneticsQH426-470ENFrontiers in Genetics, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic lung adenocarcinoma
tumor recurrence
weighted gene co-expression network analysis
hub genes
transcription factor
Genetics
QH426-470
spellingShingle lung adenocarcinoma
tumor recurrence
weighted gene co-expression network analysis
hub genes
transcription factor
Genetics
QH426-470
Zhengze Shen
Shengwei Liu
Jie Liu
Jingdong Liu
Caoyuan Yao
Weighted Gene Co-Expression Network Analysis and Treatment Strategies of Tumor Recurrence-Associated Hub Genes in Lung Adenocarcinoma
description Despite the recent progress of lung adenocarcinoma (LUAD) therapy, tumor recurrence remained to be a challenging factor that impedes the effectiveness of treatment. The objective of the present study was to predict the hub genes affecting LUAD recurrence via weighted gene co-expression network analysis (WGCNA). Microarray samples from LUAD dataset of GSE32863 were analyzed, and the modules with the highest correlation to tumor recurrence were selected. Functional enrichment analysis was conducted, followed by establishment of a protein–protein interaction (PPI) network. Subsequently, hub genes were identified by overall survival analyses and further validated by evaluation of expression in both myeloid populations and tissue samples of LUAD. Gene set enrichment analysis (GSEA) was then carried out, and construction of transcription factors (TF)–hub gene and drug–hub gene interaction network was also achieved. A total of eight hub genes (ACTR3, ARPC5, RAB13, HNRNPK, PA2G4, WDR12, SRSF1, and NOP58) were finally identified to be closely correlated with LUAD recurrence. In addition, TFs that regulate hub genes have been predicted, including MYC, PML, and YY1. Finally, drugs including arsenic trioxide, cisplatin, Jinfukang, and sunitinib were mined for the treatment of the eight hub genes. In conclusion, our study may facilitate the invention of targeted therapeutic drugs and shed light on the understanding of the mechanism for LUAD recurrence.
format article
author Zhengze Shen
Shengwei Liu
Jie Liu
Jingdong Liu
Caoyuan Yao
author_facet Zhengze Shen
Shengwei Liu
Jie Liu
Jingdong Liu
Caoyuan Yao
author_sort Zhengze Shen
title Weighted Gene Co-Expression Network Analysis and Treatment Strategies of Tumor Recurrence-Associated Hub Genes in Lung Adenocarcinoma
title_short Weighted Gene Co-Expression Network Analysis and Treatment Strategies of Tumor Recurrence-Associated Hub Genes in Lung Adenocarcinoma
title_full Weighted Gene Co-Expression Network Analysis and Treatment Strategies of Tumor Recurrence-Associated Hub Genes in Lung Adenocarcinoma
title_fullStr Weighted Gene Co-Expression Network Analysis and Treatment Strategies of Tumor Recurrence-Associated Hub Genes in Lung Adenocarcinoma
title_full_unstemmed Weighted Gene Co-Expression Network Analysis and Treatment Strategies of Tumor Recurrence-Associated Hub Genes in Lung Adenocarcinoma
title_sort weighted gene co-expression network analysis and treatment strategies of tumor recurrence-associated hub genes in lung adenocarcinoma
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/a3f7ee460a62453695bb1b0edecb5f99
work_keys_str_mv AT zhengzeshen weightedgenecoexpressionnetworkanalysisandtreatmentstrategiesoftumorrecurrenceassociatedhubgenesinlungadenocarcinoma
AT shengweiliu weightedgenecoexpressionnetworkanalysisandtreatmentstrategiesoftumorrecurrenceassociatedhubgenesinlungadenocarcinoma
AT jieliu weightedgenecoexpressionnetworkanalysisandtreatmentstrategiesoftumorrecurrenceassociatedhubgenesinlungadenocarcinoma
AT jingdongliu weightedgenecoexpressionnetworkanalysisandtreatmentstrategiesoftumorrecurrenceassociatedhubgenesinlungadenocarcinoma
AT caoyuanyao weightedgenecoexpressionnetworkanalysisandtreatmentstrategiesoftumorrecurrenceassociatedhubgenesinlungadenocarcinoma
_version_ 1718426623591579648